A feasibility study of gene gun mediated immunotherapy for renal cell carcinoma

Journal of Urology

Volumn 162, Issue 4, 1999, Pages 1259-1263

  Seigne, John ^a   Turner, Joel ^a   Diaz, Jose ^a   Hackney, Jason ^a   Pow Sang, Julio ^a   Helal, Mohamed ^a   Lockhart, Jorge ^a   Yu, Hua ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Cancer vaccines; Carcinoma, renal cell; Cytokines; Gene therapy; Immunotherapy

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PLASMID DNA; TUMOR CELL VACCINE;

ARTICLE; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE GUN; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; KIDNEY CARCINOMA; METASTASIS; MICROSCOPY; PRIORITY JOURNAL;

EID: 0032819977     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68260-2     Document Type: Article

References (17)

1. Gleave, M. E., Elhilali, M., Fradet, Y., Davis, I., Venner, P., Saad, F., Klotz, L. H., Moore, M. J., Paton, V. and Bajamonde, A.: Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. New Engl. J. Med., 338: 1265, 1998.
2. Motzer, R. J., Bander, N. H. and Nanus, D. M.: Renal-cell carcinoma. New Engl. J. Med., 335: 865, 1996.
3. Turner, J. G., Tan, J., Crucian, B. E., Sullivan, D. M., Ballester, O. F., Dalton, W. S., Yang, N. S., Burkholder, J. K. and Yu, H.: Broadened clinical utility of gene gun-mediated, granulocyte-macrophage colony-stimulating factor cDNA-based tumor cell vaccines as demonstrated with a mouse myeloma model. Hum. Gene Ther., 9: 1121, 1998.
4. Sanda, M. A., Ayyagari, S. J., Jaffee, E. M., Epstein, J. I., Clift, S. L., Cohen, L. K., Dranoff, G., Pardoll, D. M., Mulligan, R. C. and Simons, J. W.: Demonstration of a rational strategy for human prostate cancer gene therapy. J. Urol., 151: 622, 1994.
5. Connor, J., Banner, J. R., Saito, S., Heston, W., Fair, W. and Gilboa, E.: Regression of bladder tumors in mice treated with interleukin 2 gene modified tumor cells. J. Exp. Med., 177: 1127, 1993.
6. Dranoff, G., Jaffee, E., Lazenby, A. and Golumbeck, P.: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific and long lasting anti tumor immunity. Proc. Natl. Acad. Sci., 90: 3539, 1993.
7. Berns, A. J., Clift, S., Cohen, L. K., Donehower, R. C., Dranoff, G., Hauda, K. M., Jaffee, E. M., Lazenby, A. J., Levitsky, H. I. and Marshall, F. F.: Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without hGM-CSF gene transduction in patients with metastatic renal cell carcinoma. Hum. Gene Ther., 6: 347, 1995.
8. Simons, J. W., Jaffee, E. M., Weber, C. E., Levitsky, H. I., Nelson, W. G., Carducci, M. A., Lazenby, A. J., Cohen, L. K., Finn, C. C., Clift, S. M., Hauda, K. M., Beck, L. A., Leiferman, K. M., Owens, A. H., Jr., Piantadosi, S., Dranoff, G., Mulligan, R. C., Pardoll, D. M. and Marshall, F. F.: Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer. Cancer Res., 57: 1537, 1997.
9. Hsu, S. M., Raine, L. and Fanger, H.: Use of avidin biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures, J. Histochem. Cytochem., 29: 577, 1981.
10. Shi, S. R., Key, M. E. and Kalra, K. L.: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of sections. J. Histochem. Cytochem., 39: 741, 1991.
11. Wick, M. R., Cherwitz, D. L., Manivel, J. C. and Sibley, R.: Immunohistochemical findings in tumors of the kidney. In: Tumors and Tumor Like Conditions of the Kidneys and Ureters. Edited by J. N. Elbe, New York: Churchill Livingston, pp. 207-247, 1992.
12. Mahvi, D. M., Burkholder, J. K., Turner, J., Culp, J., Malter, J. S., Sondel, P. M. and Yang, N. S.: Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine. Hum. Gene Ther., 20: 1535, 1996.
13. Vile, R. and Russell, S. J.: Gene transfer technologies for the gene therapy of cancer. Gene Ther., 1: 88, 1994.
14. Ali, M., Lemoine, N. R. and Ring, C. J.: The use of DNA viruses as vectors for gene therapy. Gene Ther., 1: 367, 1994.
15. Hernandez, A., Zoller, K., Enczmann, J., Ebert, T., Schmitz-Draeger, B., Ackermann, R. and Wernet, P.: Differential transfection efficiency rates of the hGM-CSF gene into human renal cell carcinoma lines by lipofection. Cancer Gene Ther., 4: 59, 1997.
16. Wakimoto, H., Abe, J., Tsunoda, R., Aoyagi, M., Hirakawa, K. and Hamada, H.: Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4. Cancer Res., 56: 1828, 1996.
17. Mahvi, D. M., Sondel, P. M., Yang, N. S., Albertini, M. R., Schiller, J. H., Hank, J., Heiner, J., Gan, J., Swain, W. and Logrono, R.: Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma. Hum. Gene Ther., 8: 875, 1997.